指南与共识消化与肝胆胰病理细胞病理与分子病理

结直肠癌分子生物标志物检测指南:ASCP、CAP、AMP与ASCO联合推荐

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.
指南 / 共识 · Arch Pathol Lab Med · 2017-02-06

证据支持对EGFR信号通路基因进行突变检测,因其可预测抗EGFR单克隆抗体疗效,部分标志物突变具有明确预后价值。

要点

  • 推荐对结直肠癌组织进行EGFR信号通路基因突变检测,以指导抗EGFR单克隆抗体治疗。
  • 部分生物标志物突变具有明确预后价值。

核心结论

  • 证据支持对EGFR信号通路基因进行突变检测,因其提供临床可操作信息,可负向预测抗EGFR单克隆抗体靶向治疗获益。
  • 多种生物标志物的突变具有明确预后价值。

研究设计与样本

  • 由美国临床病理学会、病理学家学会、分子病理学协会与美国临床肿瘤学会召集专家组制定循证指南。
  • 进行了包含超过4000篇文章的全面文献检索。

关键数值与推荐

  • 推荐对结直肠癌组织进行EGFR信号通路基因突变检测以指导靶向治疗和常规化疗。
  • 实验室操作方案已提出以实施结直肠癌分子检测。

临床怎么用

  • 病理科应按照指南对结直肠癌组织进行分子标志物检测,为临床提供抗EGFR治疗决策和预后信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: - To develop evidence-based guideline recommendations through a systematic review of the literature to establish standard molecular biomarker testing of colorectal cancer (CRC) tissues to guide epidermal growth factor receptor (EGFR) therapies and conventional chemotherapy regimens. METHODS: - The American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology convened an expert panel to develop an evidence-based guideline to establish standard molecular biomarker testing and guide therapies for patients with CRC. A comprehensive literature search that included more than 4,000 articles was conducted. RESULTS: - Twenty-one guideline statements were established. CONCLUSIONS: - Evidence supports mutational testing for EGFR signaling pathway genes, since they provide clinically actionable information as negative predictors of benefit to anti-EGFR monoclonal antibody therapies for targeted therapy of CRC. Mutations in several of the biomarkers have clear prognostic value. Laboratory approaches to operationalize CRC molecular testing are presented.

来源:Arch Pathol Lab Med,查看原文。版权归原作者所有。

引用

  1. Sepulveda AR, Hamilton SR, Allegra CJ, et al. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. Arch Pathol Lab Med. 2017. PMID: 28165284. doi:10.5858/arpa.2016-0554-CP

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。